Nurses in the Golden State can once again obtain training in a new method to save preborn babies from the abortion pill.
Over the last decade, some pro-life doctors have worked on a method of reversing the effects of the abortion pill RU-486 – but women who have a change of heart must act quickly, says Jay Hobbs of Heartbeat International.
"If the woman changes her mind after taking the first pill involved in the abortion pill regimen, which is a chemical abortion, she can change her mind within about 72 hours – so she's got a little window there," Hobbs explains.
"If she changes her mind and decides she does not want an abortion, she can take an emergency injection of progesterone," he adds. The second medication in the chemical abortion protocol (misoprostol) should not be taken.
The treatment – which continues through the woman's first trimester of pregnancy – is supported by the American Association of Pro-Life Obstetricians & Gynecologists. The AAPLOG acknowledges the reversal process is an off-label use of an FDA-approved drug – then adds: "It is hypocritical for abortion advocates to criticize off-label use of pharmaceuticals when in fact they are widely engaging in this practice themselves" in the most common abortion pill protocols.
The California Board of Registered Nursing – which Hobbs describes as "the gold standard across the country" – decided to include the process as part of its training of nurses, but then removed it because of pressure from the abortion cartel.
Hobbs says the organization has reversed itself three times now, and the training has again received a green flag.
"... We're seeing [the board of nursing in California] look at this procedure and understand that it is in fact science-based, medicine-based," he shares, "and therefore they're able to stand against the pressure of the abortion lobby and instead allow nurses to learn about this great procedure."
Already about 350 medical providers have been trained for the protocol, and approximately 400 babies have been saved from abortion. The success rate of the treatment is about 55 percent.